Welcome to LookChem.com Sign In|Join Free
  • or
methyl 5-deoxy-5-fluoro-2,3-di-O-benzoyl-β-D-ribofuranoside is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

174174-99-3

Post Buying Request

174174-99-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174174-99-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 174174-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,1,7 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 174174-99:
(8*1)+(7*7)+(6*4)+(5*1)+(4*7)+(3*4)+(2*9)+(1*9)=153
153 % 10 = 3
So 174174-99-3 is a valid CAS Registry Number.

174174-99-3Relevant academic research and scientific papers

Synthesis of 5'-fluoro-5'-deoxy- and 5'-amino-5'-deoxytoyocamycin and sangivamycin and some related derivatives

Sharma,Li,Ledvina,Bobek

, p. 1831 - 1852 (2007/10/02)

A series of 5'-substituted analogs of toyocamycin were prepared by condensation of silylated 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine with protected 5-azido-5-deoxy- or 5-fluoro-5-deoxyribofuranose followed by debromination and deblocking. Alternatively, 5'-azido-5'-deoxytoyocamycin was prepared by azidation of toyocamycin. Conversion of the 5-nitrile function of the toyocamycin derivatives into a carboxamide or a thiocarboxamide gave the corresponding analogs of sangivamycin or thiosangivamycin while reduction of the 5'-azido-5'-deoxy nucleosides provided 5'-amino-5'-deoxy derivatives.

New Adenosine Kinase Inhibitors with Oral Antiinflammatory Activity: Synthesis and Biological Evaluation

Cottam, Howard B.,Wasson, D. Bruce,Shih, Hsien C.,Raychaudhuri, Anil,Pasquale, Gene Di,Carson, Dennis A.

, p. 3424 - 3430 (2007/10/02)

Several 5-iodotubercidin analogues in the pyrazolopyrimidine ring system were synthesized as potential inhibitors of adenosine kinase by a direct Lewis acid-catalyzed glycosylation procedure using both the preformed carbohydrate and the heterocyclic base as starting materials.The 5'-hydroxyl, -chloro, -azido, -deoxy, -amino, and -fluoro derivatives were prepared and evaluated in three systems for biological activity relative to adenosine, the true substrate, and 5-iodotubercidin, a known inhibitor.First, each compound was studied kinetically for inhibition of purified human placental adenosine kinase activity.The order of potency was: iodotubercidin > hydroxyl > amino deoxy > fluoro > chloro >> azido.The Ki values for the 5'-hydroxyl and 5'-amino compounds, the two most potent inhibitors, were 80 and 150 nM, respectively.The inhibition appeared to be essentially competitive in nature, although a noncompetitive component of significance for the more potent inhibitors cannot be ruled out.Second, a bioassay was conducted in which the toxicity of 6-methylmercaptopurine riboside toward human CEM lymphoblasts was reversed by varying concentrations of the compounds.The order of effectiveness of the compounds in this system, representing a functional inhibition of adenosine kinase in cultured cells, was about the same as that with the purified enzyme, except that the 5'-chloro and 5'-fluoro compounds were ineffective.Third, the 5'-hydroxyl derivative was evaluated in vivo in a rat pleurisy inflammation model and displayed biological activity at a dose of 30 mg/kg given orally.Finally, the in vitro toxicity of each compound was assessed in CEM lymphoblasts.Results indicated that the two most potent inhibitors in the pyrazolopyrimidine ring system, the 5'-hydroxyl (7) and the 5'-amino (20), were 15-fold and 75-fold, respectively, less growth inhibitory than 5-iodotubercidin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 174174-99-3